Actively Recruiting
Evaluating Botulinum Toxin Type A Injection for Surgical Wound Healing After Laparoscopic Colectomy at Thong Nhat Hospital
Led by Pham Ngoc Thach University of Medicine · Updated on 2026-08-31
60
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of botulinum toxin type A BTX-A injections as an additional treatment for wound healing in adult patients undergoing laparoscopic colectomy. This randomized controlled study compares wound healing and scar outcomes between participants receiving BTX-A injections along the surgical incision and those receiving routine postoperative wound care without the injection. Participants are randomly assigned to one of two groups the intervention group receives intradermal BTX-A injections along both sides of the surgical incision after wound closure, administered by the same physician for consistency. The control group receives standard postoperative wound care without the BTX-A injection. Both groups are then followed to assess wound healing and scar appearance. During the study, participants undergo evaluations of wound healing using the REEDA scale on postoperative days 0, 7, and 14, and scar appearance using the modified Stony Brook Scar Evaluation Scale on days 7, 14, and 30. Researchers also monitor any adverse events related to BTX-A injection from administration through day 30. Participants receive routine follow-up visits to track these outcomes and the overall safety of the intervention.
CONDITIONS
Brief Title
Botulinum Toxin Type A for Wound Healing After Laparoscopic Colectomy
Research Team
T
To Trinh Ngoc Chau, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here